As of October 2026 Iovance Biotherapeutics has a market cap of $6.43 Billion USD. This makes Iovance Biotherapeutics the world's 2702th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Oct 2nd, 2026 the market cap of Iovance Biotherapeutics was reported to be: